Review

Treatment of Lupus Nephritis

Volume 15 · Issue 2 Publish Date: February 14, 2019
Full Text PDF
Kübra KAYNAR
Karadeniz Teknik Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Nefroloji BD, Trabzon
KAYNAR, K. (2019). Treatment of Lupus Nephritis. Turkish Journal of Nephrology, 15(2), 71–76. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/519
Full Text Full Text PDF

Abstract

Renal involvement is the cause of major mortality and morbidity of systemic lupus erythematosus (SLE) disease. Although regimes including pulse cyclophosphamide and corticosteroid are the most effective treatment modalities, they are not ideal for toxicity. The increase in neoplasm risk, infections and gonadal toxicity are the major concerns about cyclophosphamide. While choosing the treatment of severe lupus nephritis, risk benefit ratio should be thought individually. Clinical status, activity degree, chronicity in renal histology, tolerability of the patient, presence of infection, cytopenia, extrarenal involvement should be evaluated in detail. The treatment of lupus nephritis was discussed with this review.

Similar Articles

Article Info
Published In
Journal Turkish Journal of Nephrology
Volume / Issue Volume 15 · Issue 2
Pages 71-76
History
Published Online February 14, 2019
Copyright
Affiliations
Kübra KAYNAR
Karadeniz Teknik Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Nefroloji BD, Trabzon
Cite this Article
KAYNAR, K. (2019). Treatment of Lupus Nephritis. Turkish Journal of Nephrology, 15(2), 71–76. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/519
Outlines